Back to VRDN
Paradigm Biocapital Advisors LP → VRDN
Paradigm Biocapital Advisors LP VRDN Position History
Viridian Therapeutics, Inc. • Healthcare
Quarters held
4
Latest value
$170M
Q3 2026
Peak value
$170M
First seen
Q4 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q4 2025 | $44.9M |
| Q1 2026 | $61.6M |
| Q2 2026 | $123.5M |
| Q3 2026 | $170M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $170M | 8.26M | — | — |
| Q2 2026 | $123.5M | 6.72M | — | — |
| Q1 2026 | $61.6M | 3.15M | — | — |
| Q4 2025 | $44.9M | 1.44M | — | — |